All news
Investigating the impact of anti-inflammatory drugs on Alzheimer’s disease
18 October 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/10/Nurse-consulting-patient-and-family-member-150x150.jpg)
A research study exploring the impact specialist anti-inflammatory drugs have on Alzheimer’s disease symptoms is looking for volunteers in London, Plymouth, Guildford and Southampton. The EXploratory PLatform trial on Anti-INflammatory agents in Alzheimer’s Disease, or EXPLAIN-AD for short, will be evaluating the effectiveness and safety of anti-inflammatory agents on common Alzheimer’s symptoms – including memory, […]
Lecanemab – a potential new treatment for Alzheimer’s disease
28 September 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/09/GettyImages-650160957-150x150.jpg)
News that a potential treatment for early stage Alzheimer’s disease can slow cognitive decline is a significant development in dementia research. About the drug Lecanemab is an antibody that is designed to remove toxic beta-amyloid deposits; proteins that build up in the brains of people with Alzheimer’s disease. Following phase 3 clinical trials, pharmaceutical companies […]
Diabetes drug to be tested as a potential treatment for Alzheimer’s disease
7 September 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/08/Evoke_Stocksy_1868588_lowres-1-150x150.jpg)
Clinical trials across England and Scotland are underway to investigate if an existing diabetes medicine can potentially work as a disease-modifying option for early-stage Alzheimer’s disease. Novo Nordisk is now working alongside Join Dementia Research to investigate if the medicine, known as semaglutide, could also benefit people living with early Alzheimer’s disease. What the study […]
Could an anti-sickness drug treat hallucinations?
16 August 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/08/butterflies-made-from-water-1-150x150.jpg)
A national research study is investigating whether a readily available anti-sickness drug could treat dementia-related hallucinations. The Trial of Ondansetron as a Parkinson’s HAllucinations Treatment, or TOP HAT study, is recruiting volunteers across England, Scotland and Wales to evaluate whether ondansetron, an anti-sickness drug used in the NHS, could also be used for treating hallucinations […]
New volunteers sign up as Prime Minister launches national dementia mission
15 August 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/08/GettyImages-176216436-150x150.jpg)
On 14 August 2022, the Prime Minister launched a national mission to tackle dementia in memory of the late Dame Barbara Windsor. He called for volunteers to join ‘Babs’ Army’ and sign up to Join Dementia Research. Since then we’ve welcomed hundreds of new people to the service from all over the UK. About Join […]
Shaping the future of early-stage dementia support
19 July 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/07/GettyImages-1160945486-1-150x150.jpg)
A pioneering international study is exploring how health promotion and self-management programmes could be used to support people with early-stage dementia and improve their health outcomes. The Self-management and HeAlth Promotion in early-stage dementia with E-learning for carers study, or SHAPE for short, is looking to recruit people with a mild to moderate dementia diagnosis […]
Clinical study to assess potential Alzheimer’s drug
13 July 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/07/GettyImages-1328467880-150x150.jpg)
There are almost one million people with dementia in the UK and the most common cause is Alzheimer’s disease. Researchers from University College London (UCL) with funding from the National Institute for Health and Care Research are testing a new approach to the treatment of mild Alzheimer’s disease in the DESPIAD (DEpletion of SaP in […]
Global Brain Health Survey Findings
9 June 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/06/GettyImages-1304263578-150x150.jpg)
Although the causes of dementia are not yet known, we do know which lifestyle choices such as diet, exercise and smoking can affect brain health and the chances of developing dementia. Until now, there has been little insight into the perceptions of brain health around the world. In June 2019 an anonymous online survey ‘The […]
Volunteer survey findings 2021
23 May 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/05/GettyImages-1317100523-150x150.jpg)
Every year we ask our Join Dementia Research volunteers to tell us about their experiences of the service via a questionnaire. This helps us to understand what we are doing well and enables us to identify areas for improvement. Engagement You may have noticed some changes to the survey this year; we reduced the number […]
Dementia Action Week 2022
20 May 2022
![](https://news.joindementiaresearch.nihr.ac.uk/wp-content/uploads/2022/05/LMS_0923-1-150x150.jpg)
This year, Dementia Action Week takes place 16-22 May in England, Wales and Northern Ireland. Dementia podcast With this being a key opportunity in the calendar to raise awareness about dementia, we are delighted to share a new podcast with Professor John O’Brien, the NIHR National Specialty Lead for Dementia. In this podcast, Professor O’Brien […]